September 13: Message from Dr. Eva Feldman

September 13, 2020

Dear Friends,

Fall is already off to a fast start both inside the laboratory and out. I am excited to announce details about our second installment to the NeuroNetwork for Emerging Therapies Mini Symposium Series. “Climate Change, the Environment and Health” promises to be a very insightful half hour covering the many ways in which climate change has negatively affected our environment and, in turn, how the environment impacts our health. Please join us for this Zoom webinar on Thursday, October 15, at 2 p.m.

I will be joined by two of our NeuroNetwork members: Dr. Stuart Batterman, School of Public Health, and Dr. Stephen Goutman, Director of the Pranger ALS Clinic. We will also welcome special guest Dr. Jonathan Overpeck, who is Dean of the U-M School for Environment and Sustainability. Please register using the link below and submit any questions you would like us to answer.

Oct. 15 Symposium Graphic Climate Change, the Environment & Health
Oct. 15 Symposium Speakers: Batterman, Goutman, Overpeck, Feldman

I am also looking forward to the Women SEEN 2020: Making an Impact virtual conference that is set for Friday, September 25, at 10:30 a.m. Register here for the Zoom webinar that will include me and many other incredibly accomplished women from various industries. This event is a follow up to the SEEN Magazine Women’s Issue that published in May.

I want to highlight the work of Drs. Stephen Goutman and Brian Callaghan. Dr. Goutman was co-author of a New England Journal of Medicine paper that reported promising results from an ALS drug trial that included the U-M Pranger ALS Clinic. Dr. Callaghan’s recent research of obesity and neuropathy led to the American Neurological Association selecting him as its 2020 Wolfe Neuropathy Research Prize honoree.

We are very interested on the health consequences of obesity. I presented Grand Rounds for the Michigan Medicine Department of Neurology and my talk was titled “The Neurological Complications of Obesity.” A recap video is below. Additionally, Brain & Life magazine, which is produced by the ANA, interviewed me and Dr. Callaghan about obesity's interference with lung and immune system function, which is especially problematic for COVID-19 patients. As a result of that story, I spoke to a Toledo radio show, “A Firm Foundation for Life,” about the obesity/COVID-19 relationship.

I’ll be virtually joining Grand Valley State University’s Hauenstein Center for Professional Studies on October 9 to speak to their community about my leadership experience as a clinician-scientist.

Lastly, we published three more scientific articles last month, one each in ALS, diabetes and Alzheimer’s disease, so we’re closing in on 30 total papers for 2020! We are also in the midst of grant-writing season. I’m especially interested to watch the progress of the projects we have developed with our international NeuroNetwork members.

As always, please follow our latest updates on FacebookTwitterLinkedIn and here on our website. Thank you for your support and please reach out to me if I can help you in any way.

Warmest regards,

Eva L. Feldman, MD, PhD
Russell N. DeJong Professor of Neurology
Director, NeuroNetwork for Emerging Therapies
Director, ALS Center of Excellence